US patent reforms could re-establish gene patent eligibility, industry experts warn
06-06-2019
Gilead claims US government PrEP patents are invalid
20-05-2019
Generic of Gilead’s HIV pre-exposure drug coming to market in 2020
09-05-2019
roschetzky / iStockphoto
The Information Technology and Innovation Foundation (ITIF) think tank has called on the US National Institutions of Health (NIH) to maintain IP protection amid calls to “break” patents in order to lower drug prices.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Information Technology and Innovation Foundation, report, PrEP, National Institutes of Health, patent breaking, innovation, prices, Truvada, Bayh-Dole Act
